Table 4.
The adjusted regression coefficients of Yin-Xu, Yang-Xu, and Stasis on diabetics with the quality of life measured by diabetes impact measurement scales#.
| Variable | Symptoms | Related morale | Social role | Well-being | ||||
|---|---|---|---|---|---|---|---|---|
| β (SE) | Standardized β | β (SE) | Standardized β | β (SE) | Standardized β | β (SE) | Standardized β | |
| Yin-Xu (no as reference group) | ||||||||
| Yes | −4.00 (0.42)∗∗∗ | −0.32 | −1.63 (0.40)∗∗∗ | −0.16 | −0.88 (0.37)∗ | −0.09 | −0.85 (0.33)∗∗ | −0.11 |
| Yang-Xu (no as reference group) | ||||||||
| Yes | −2.58 (0.58)∗∗∗ | −0.15 | −0.76 (0.56) | −0.06 | −0.08 (0.52) | −0.01 | −0.35 (0.46) | 0.03 |
| Stasis (no as reference group) | ||||||||
| Yes | −2.34 (0.59)∗∗∗ | −0.14 | −2.97 (0.57)∗∗∗ | −0.22 | −1.65 (0.53)∗∗ | −0.12 | −1.71 (0.47) | −0.15 |
| R ² | 45% | 23% | 30% | 20% | ||||
(1) #Parameter estimates (SE).
(2) *P < 0.05; **P < 0.01; ***P < 0.001.
(3) Parameter estimates were from multiple linear regression adjusting for age, height, weight, smoking, physical activity, fasting glucose, duration of diabetes, glycosylated hemoglobin, triglycerides, GPT, LDL-C, creatinine, GFR, diabetic neuropathy, diabetic retinopathy, metabolic syndrome, and combined morbidity.